Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buser

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bone Marrow Transplantation|April 5, 2022
Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donorsM Rüesch, S Amar El Dusouqui, E Buhrfeind, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activityVadim Y Dudkin, Cheng Wang, Kenneth L Arrington, et al.
Molecular Pharmacology|October 7, 2015
Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease ActivityNestor O Concha, Angela Smallwood, William Bonnette, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IChristopher J Dinsmore, C Blair Zartman, Jeffrey M Bergman, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferasesThomas J Tucker, Marc T Abrams, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2007
Kinesin spindle protein (KSP) inhibitors. Part V: discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by beta-fluorination to overcome cellular efflux by P-glycoproteinChristopher D Cox, Michael J Breslin, David B Whitman, et al.
The Journal of Biological Chemistry|July 9, 2011
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survivalJohn M Luk, Julja Burchard, Chunsheng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Journal of Medicinal Chemistry|June 27, 2003
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agentsS Jane deSolms, Terrence M Ciccarone, Suzanne C MacTough, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Bone Marrow Transplantation|April 5, 2022
Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donorsM Rüesch, S Amar El Dusouqui, E Buhrfeind, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activityVadim Y Dudkin, Cheng Wang, Kenneth L Arrington, et al.
Molecular Pharmacology|October 7, 2015
Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease ActivityNestor O Concha, Angela Smallwood, William Bonnette, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IChristopher J Dinsmore, C Blair Zartman, Jeffrey M Bergman, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferasesThomas J Tucker, Marc T Abrams, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2007
Kinesin spindle protein (KSP) inhibitors. Part V: discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by beta-fluorination to overcome cellular efflux by P-glycoproteinChristopher D Cox, Michael J Breslin, David B Whitman, et al.
The Journal of Biological Chemistry|July 9, 2011
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survivalJohn M Luk, Julja Burchard, Chunsheng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Journal of Medicinal Chemistry|June 27, 2003
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agentsS Jane deSolms, Terrence M Ciccarone, Suzanne C MacTough, et al.
Pageof 11